Jason Hanson

Jason D.
Hanson is an Independent Non-Executive Director at BullFrog AI Holdings, Inc. since 2023.
Formerly, Mr. Hanson was President, Chief Executive Officer & Director at enGene, Inc. from 2018 to 2024, and Chief Executive Officer & Executive Director at enGene Therapeutics, Inc. from 2023 to 2024.
Served as Chairman & Executive Vice President at Bausch Health Cos., Inc. from 2012 to 2013.
Held the position of Director at Ohana Biosciences, Inc. from 2017 to 2018 and at The Electronic Transactions Association.
Was Chief Operating Officer & Executive Vice President at Medicis Pharmaceutical Corp.
from 2011 to 2012.
Worked as EVP-Strategy, Development & General Counsel at NuVasive LLC from 2015 to 2016.
Served as General Counsel-Americas at GE Medical Systems, Inc. from 1999 to 2004.
Held the role of Vice President & General Counsel at GE Healthcare AG.
Was Vice President at GE Aerospace from 2014 to 2015.
Worked as General Counsel at GE Healthcare IVD Technologies in 2006.
Education includes undergraduate studies at Cornell University and graduate studies at Duke University School of Law.